# BHV-7000 Open-Label Extension Bipolar Mania Study

> **NCT06423794** · PHASE2 · TERMINATED · sponsor: **Biohaven Therapeutics Ltd.** · enrollment: 94 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** BHV-7000

## Key facts

- **NCT ID:** NCT06423794
- **Lead sponsor:** Biohaven Therapeutics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-06-24
- **Primary completion:** 2025-04-25
- **Final completion:** 2025-04-25
- **Target enrollment:** 94 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06423794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06423794, "BHV-7000 Open-Label Extension Bipolar Mania Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06423794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*